Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desflurane vs TIVA on Recovery and Prognosis in Pancreatic and Bile Duct Cancer Surgery
NCT03447691Unknown
- Sponsor
- Yonsei University
- Start
- Aug 2017
- Primary completion
- Aug 2022
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Trial of desflurane in pancreatic cancer (PC) and Common Bile Duct Cancer (2 arms), sponsored by Yonsei University. Primary endpoint: Quality of Recovery 40. Status: unknown.
02
Drugs
desflurane
03
Conditions
pancreatic cancer (PC)Common Bile Duct Cancer
Beyond the preview
Go deeper on NCT03447691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03447691.